A GSTM3 polymorphism associated with an etiopathogenetic mechanism in Alzheimer disease

Neurobiology of Aging

Volumn 31, Issue 1, 2010, Pages 34-45

  Maes, Olivier C ^a,b   Schipper, Hyman M ^b,d   Chong, George ^c,d   Chertkow, Howard M ^b,d   Wang, Eugenia ^a  

^a University of Louisville School of Medicine   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Aging; Alzheimer Disease; Antioxidant defense; Blood mononuclear cell; DNA repair; Gender; Glutathione S transferase; Microarray profiling; Single nucleotide polymorphism

Indexed keywords

ACTIN BINDING PROTEIN; AMYLOID BETA PROTEIN; ANTIOXIDANT; APOLIPOPROTEIN E4; DNA; FERRITIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M3; INTERFERON REGULATORY FACTOR 2; MESSENGER RNA; MINICHROMOSOME MAINTENANCE PROTEIN 3; OSTEOGENIC PROTEIN 1; RIBOSOME PROTEIN; RNA; TRANSCRIPTION FACTOR POU; UBIQUITIN CONJUGATING ENZYME E2; URIDINE DIPHOSPHATE GLUCOSE 4 EPIMERASE;

AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DNA EXTRACTION; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; MONONUCLEAR CELL; NEUROPSYCHOLOGICAL TEST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SPECIFICITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIOXIDANTS; BRAIN; DNA MUTATIONAL ANALYSIS; DNA REPAIR; DOWN-REGULATION; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; POLYMORPHISM, GENETIC; RNA, MESSENGER;

EID: 70449526835     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2008.03.007     Document Type: Article

References (55)

1. Berg L., Hughes C.P., Coben L.A., Danziger W.L., Martin R.L., and Knesevich J. Mild senile dementia of Alzheimer type: research diagnostic criteria, recruitment, and description of a study population. J. Neurol. Neurosurg. Psychiatry 45 11 (1982) 962-968
2. Bertram L., McQueen M.B., Mullin K., Blacker D., and Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 39 1 (2007) 17-23
3. Blalock E.M., Geddes J.W., Chen K.C., Porter N.M., Markesbery W.R., and Landfield P.W. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc. Natl. Acad. Sci. U.S.A. 101 7 (2004) 2173-2178
4. Brookes A.J., and Prince J.A. Genetic association analysis: lessons from the study of Alzheimers disease. Mutat. Res. 573 1-2 (2005) 152-159
5. Bullido M.J., Guallar-Castillon P., Artiga M.J., Ramos M.C., Sastre I., Aldudo J., Frank A., Coria F., Rodriguez-Artalejo F., and Valdivieso F. Alzheimer's risk associated with human apolipoprotein E, alpha-2 macroglobulin and lipoprotein receptor related protein polymorphisms: absence of genetic interactions, and modulation by gender. Neurosci. Lett. 289 3 (2000) 213-216
6. Bullido M.J., Martinez-Garcia A., Artiga M.J., Aldudo J., Sastre I., Gil P., Coria F., Munoz D.G., Hachinski V., Frank A., and Valdivieso F. A TAP2 genotype associated with Alzheimer's disease in APOE4 carriers. Neurobiol. Aging 28 4 (2007) 519-523
7. Cacabelos R., Fernandez-Novoa L., Lombardi V., Kubota Y., and Takeda M. Molecular genetics of Alzheimer's disease and aging. Methods Find. Exp. Clin. Pharmacol. 27 Suppl. A (2005) 1-573
8. Cecchi C., Latorraca S., Sorbi S., Iantomasi T., Favilli F., Vincenzini M.T., and Liguri G. Gluthatione level is altered in lymphoblasts from patients with familial Alzheimer's disease. Neurosci. Lett. 275 2 (1999) 152-154
9. Chartier-Harlin M.C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., Berr C., Vidal O., Roques P., Gourlet V., et al. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3 4 (1994) 569-574
10. Chertkow H., Bergman H., Schipper H.M., Gauthier S., Bouchard R., Fontaine S., and Clarfield A.M. Assessment of suspected dementia. Can. J. Neurol. Sci. 28 Suppl. 1 (2001) S28-S41
11. Chertkow H., Nasreddine Z., Joanette Y., Drolet V., Kirk J., Massoud F., Belleville S., and Bergman H. Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis. Alzheimers Demen. 3 4 (2007) 266-282
12. Chesler E.J., Lu L., Shou S., Qu Y., Gu J., Wang J., Hsu H.C., Mountz J.D., Baldwin N.E., Langston M.A., Threadgill D.W., Manly K.F., and Williams R.W. Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nat. Genet. 37 3 (2005) 233-242
13. Coon K.D., Myers A.J., Craig D.W., Webster J.A., Pearson J.V., Lince D.H., Zismann V.L., Beach T.G., Leung D., Bryden L., Halperin R.F., Marlowe L., Kaleem M., Walker D.G., Ravid R., Heward C.B., Rogers J., Papassotiropoulos A., Reiman E.M., Hardy J., and Stephan D.A. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J. Clin. Psychiatry 68 4 (2007) 613-618
14. Cortez D., Glick G., and Elledge S.J. Minichromosome maintenance proteins are direct targets of the ATM and ATR checkpoint kinases. Proc. Natl. Acad. Sci. U.S.A. 101 27 (2004) 10078-10083
15. Emahazion T., Feuk L., Jobs M., Sawyer S.L., Fredman D., St Clair D., Prince J.A., and Brookes A.J. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet. 17 7 (2001) 407-413
16. Ertekin-Taner N. Genetics of Alzheimer's disease: a centennial review. Neurol. Clin. 25 3 (2007) 611-667 v
17. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 3 (1975) 189-198
18. Fratelli M., Goodwin L.O., Orom U.A., Lombardi S., Tonelli R., Mengozzi M., and Ghezzi P. Gene expression profiling reveals a signaling role of glutathione in redox regulation. Proc. Natl. Acad. Sci. U.S.A. 102 39 (2005) 13998-14003
19. Hayes J.D., and Strange R.C. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61 3 (2000) 154-166
20. Hiort O., Wodtke A., Struve D., Zollner A., and Sinnecker G.H. Detection of point mutations in the androgen receptor gene using non-isotopic single strand conformation polymorphism analysis. German Collaborative Intersex Study Group. Hum. Mol. Genet. 3 7 (1994) 1163-1166
21. Hixson J.E., and Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31 3 (1990) 545-548
22. Hsiung G.Y., Sadovnick A.D., and Feldman H. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ 171 8 (2004) 863-867
23. Kawas C.H., and Corrada M.M. Alzheimer's and dementia in the oldest-old: a century of challenges. Curr. Alzheimer Res. 3 5 (2006) 411-419
24. Lacelle C., Riol H., Xu S., Tang Y.J., Wang Y.S., Chuang Y.L., Lin H.S., Chang M.C., Liang J., and Wang E. Blood-sample processing for the study of age-dependent gene expression in peripheral blood mononuclear cells. J. Gerontol. A Biol. Sci. Med. Sci. 57 7 (2002) B285-B287
25. Lamsa, R., Helisalmi, S., Herukka, S.K., Tapiola, T., Pirttila, T., Vepsalainen, S., Hiltunen, M., Soininen, H., in press. Genetic study evaluating LDLR polymorphisms and Alzheimer's disease. Neurobiol. Aging. doi:10.1016/j.neurobiolaging.2006.12.009.
26. Leverenz J.B., Yu C.E., and Schellenberg G.D. Aging-associated neuropathology in Werner syndrome. Acta Neuropathol. (Berl.) 96 4 (1998) 421-424
27. Li Y., Nowotny P., Holmans P., Smemo S., Kauwe J.S., Hinrichs A.L., Tacey K., Doil L., van Luchene R., Garcia V., Rowland C., Schrodi S., Leong D., Gogic G., Chan J., Cravchik A., Ross D., Lau K., Kwok S., Chang S.Y., Catanese J., Sninsky J., White T.J., Hardy J., Powell J., Lovestone S., Morris J.C., Thal L., Owen M., Williams J., Goate A., and Grupe A. Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene family. Proc. Natl. Acad. Sci. U.S.A. 101 44 (2004) 15688-15693
28. Li Y., Zhou M., Marion M.J., Lee S., and Brandt-Rauf P.W. Polymorphisms in glutathione S-transferases in French vinyl chloride workers. Biomarkers 10 1 (2005) 72-79
29. Li Y.J., Oliveira S.A., Xu P., Martin E.R., Stenger J.E., Scherzer C.R., Hauser M.A., Scott W.K., Small G.W., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Pahwa R., Stern M.B., Hiner B.C., Jankovic J., Goetz C.G., Mastaglia F., Middleton L.T., Roses A.D., Saunders A.M., Schmechel D.E., Gullans S.R., Haines J.L., Gilbert J.R., Vance J.M., Pericak-Vance M.A., Hulette C., and Welsh-Bohmer K.A. Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson disease. Hum. Mol. Genet. 12 24 (2003) 3259-3267
30. Lovell M.A., Xie C., and Markesbery W.R. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51 6 (1998) 1562-1566
31. Maes O.C., Xu S., Yu B., Chertkow H.M., Wang E., and Schipper H.M. Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol. Aging 28 12 (2007) 1795-1809
32. Masella R., Di Benedetto R., Vari R., Filesi C., and Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J. Nutr. Biochem. 16 10 (2005) 577-586
33. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 7 (1984) 939-944
34. Mecocci P., Polidori M.C., Cherubini A., Ingegni T., Mattioli P., Catani M., Rinaldi P., Cecchetti R., Stahl W., Senin U., and Beal M.F. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch. Neurol. 59 5 (2002) 794-798
35. Migliore L., Fontana I., Trippi F., Colognato R., Coppede F., Tognoni G., Nucciarone B., and Siciliano G. Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol. Aging 26 5 (2005) 567-573
36. Moreira P.I., Honda K., Liu Q., Santos M.S., Oliveira C.R., Aliev G., Nunomura A., Zhu X., Smith M.A., and Perry G. Oxidative stress: the old enemy in Alzheimer's disease pathophysiology. Curr. Alzheimer Res. 2 4 (2005) 403-408
37. Nadon N.L., Mohr D., and Becker K.G. National Institute on Aging microarray facility-resources for gerontology research. J. Gerontol. A Biol. Sci. Med. Sci. 60 4 (2005) 413-415
38. Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541 1 (1991) 163-166
39. Ray S., Britschgi M., Herbert C., Takeda-Uchimura Y., Boxer A., Blennow K., Friedman L.F., Galasko D.R., Jutel M., Karydas A., Kaye J.A., Leszek J., Miller B.L., Minthon L., Quinn J.F., Rabinovici G.D., Robinson W.H., Sabbagh M.N., So Y.T., Sparks D.L., Tabaton M., Tinklenberg J., Yesavage J.A., Tibshirani R., and Wyss-Coray T. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. Nat. Med. 13 11 (2007) 1359-1362
40. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 8 (1993) 1467-1472
41. Schindowski K., Kratzsch T., Peters J., Steiner B., Leutner S., Touchet N., Maurer K., Czech C., Pradier L., Frolich L., Muller W.E., and Eckert A. Impact of aging: sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer's disease. Neuromol. Med. 4 3 (2003) 161-178
42. Schipper H.M. Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res. Rev. 3 3 (2004) 265-301
43. Schipper H.M., Chertkow H., Mehindate K., Frankel D., Melmed C., and Bergman H. Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology 54 6 (2000) 1297-1304
44. Schulz J.B., Lindenau J., Seyfried J., and Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur. J. Biochem. 267 16 (2000) 4904-4911
45. Spalletta G., Bernardini S., Bellincampi L., Federici G., Trequattrini A., Ciappi F., Bria P., Caltagirone C., and Bossu P. Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease. Am. J. Geriatr. Psychiatry 15 10 (2007) 879-887
46. Tabner B.J., El-Agnaf O.M., Turnbull S., German M.J., Paleologou K.E., Hayashi Y., Cooper L.J., Fullwood N.J., and Allsop D. Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia. J. Biol. Chem. 280 43 (2005) 35789-35792
47. Taguchi K., Yamagata H.D., Zhong W., Kamino K., Akatsu H., Hata R., Yamamoto T., Kosaka K., Takeda M., Kondo I., and Miki T. Identification of hippocampus-related candidate genes for Alzheimer's disease. Ann. Neurol. 57 4 (2005) 585-588
48. Tchaikovskaya T., Fraifeld V., Urphanishvili T., Andorfer J.H., Davies P., and Listowsky I. Glutathione S-transferase hGSTM3 and ageing-associated neurodegeneration: relationship to Alzheimer's disease. Mech. Ageing Dev. 126 2 (2005) 309-315
49. Tetlow N., Robinson A., Mantle T., and Board P. Polymorphism of human mu class glutathione transferases. Pharmacogenetics 14 6 (2004) 359-368
50. Tsurimoto T., Shinozaki A., Yano M., Seki M., and Enomoto T. Human Werner helicase interacting protein 1 (WRNIP1) functions as a novel modulator for DNA polymerase delta. Genes Cells 10 1 (2005) 13-22
51. Webster J.A., Myers A.J., Pearson J.V., Craig D.W., Hu-Lince D., Coon K.D., Zismann V.L., Beach T., Leung D., Bryden L., Halperin R.F., Marlowe L., Kaleem M., Huentelman M.J., Joshipura K., Walker D., Heward C.B., Ravid R., Rogers J., Papassotiropoulos A., Hardy J., Reiman E.M., and Stephan D.A. Sorl1 as an Alzheimer's disease predisposition gene?. Neuro-degenerative Dis. 5 2 (2008) 60-64
52. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Nordberg A., Backman L., Albert M., Almkvist O., Arai H., Basun H., Blennow K., de Leon M., DeCarli C., Erkinjuntti T., Giacobini E., Graff C., Hardy J., Jack C., Jorm A., Ritchie K., van Duijn C., Visser P., and Petersen R.C. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 256 3 (2004) 240-246
53. Xie C., Lovell M.A., and Markesbery W.R. Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity. Free Radic. Biol. Med. 25 8 (1998) 979-988
54. Xu P.T., Li Y.J., Qin X.J., Scherzer C.R., Xu H., Schmechel D.E., Hulette C.M., Ervin J., Gullans S.R., Haines J., Pericak-Vance M.A., and Gilbert J.R. Differences in apolipoprotein E3/3 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Neurobiol. Dis. 21 2 (2006) 256-275
55. Yoshimura K., Nakano H., Yokoyama K., and Nakayama M. High iron storage levels are associated with increased DNA oxidative injury in patients on regular hemodialysis. Clin. Exp. Nephrol. 9 2 (2005) 158-163